{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:27:22Z","timestamp":1791502042429,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","award":["ASAP000420"],"award-info":[{"award-number":["ASAP000420"]}],"id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107053","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:25:31Z","timestamp":1755041131000},"page":"107053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models"],"prefix":"10.1016","volume":"215","author":[{"given":"Sara","family":"Lucas-Del-Pozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Uras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Fierli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Lentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Koletsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lazaro-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yin","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.V.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107053_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2018.01.012","article-title":"Alpha galactosidase a activity in Parkinson\u2019s disease","volume":"112","author":"Alcalay","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107053_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae109","article-title":"Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial","author":"Babu","year":"2024","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nbd.2025.107053_bb0015","article-title":"The PIKfyve complex regulates the early melanosome homeostasis required for physiological amyloid formation","volume":"132","author":"Bissig","year":"2019","journal-title":"J. Cell Sci."},{"issue":"9","key":"10.1016\/j.nbd.2025.107053_bb0020","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1083\/jcb.201711083","article-title":"Characterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neurons","volume":"217","author":"Cheng","year":"2018","journal-title":"J. Cell Biol."},{"issue":"7149","key":"10.1016\/j.nbd.2025.107053_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature05876","article-title":"Mutation of FIG 4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J","volume":"448","author":"Chow","year":"2007","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.nbd.2025.107053_bb0030","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.213587","article-title":"Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence","volume":"131","author":"Choy","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2025.107053_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2018.05.012","article-title":"TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: molecular mechanisms, cellular processes, and emerging therapeutic opportunities","volume":"122","author":"Cortes","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.nbd.2025.107053_bb0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuron.2019.09.001","article-title":"Stress-induced cellular clearance is mediated by the SNARE protein ykt6 and disrupted by alpha-Synuclein","volume":"104","author":"Cuddy","year":"2019","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.nbd.2025.107053_bb0045","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"issue":"19","key":"10.1016\/j.nbd.2025.107053_bb0050","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2025.107053_bb0055","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1038\/ncomms8314","article-title":"Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation","volume":"6","author":"Dettmer","year":"2015","journal-title":"Nat. Commun."},{"issue":"31","key":"10.1016\/j.nbd.2025.107053_bb0060","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1073\/pnas.1505953112","article-title":"KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity","volume":"112","author":"Dettmer","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.nbd.2025.107053_bb0065","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1093\/hmg\/ddx227","article-title":"Loss of native alpha-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells","volume":"26","author":"Dettmer","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"41","key":"10.1016\/j.nbd.2025.107053_bb0070","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein","volume":"31","author":"Ebrahimi-Fakhari","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1471-4159.2000.0750991.x","article-title":"Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells","volume":"75","author":"Encinas","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107053_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147349","article-title":"Crowded organelles, lipid accumulation, and abnormal membrane tubulation in cellular models of enhanced alpha-synuclein membrane interaction","volume":"1758","author":"Ericsson","year":"2021","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.nbd.2025.107053_bb0085","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200905","article-title":"Chloroquine and bafilomycin a mimic lysosomal storage disorders and impair mTORC1 signalling","volume":"40","author":"Fedele","year":"2020","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.nbd.2025.107053_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.nbd.2025.107053_bb0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on Parkinson disease","volume":"84","author":"Gan-Or","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107053_bb0100","first-page":"1093","article-title":"Identification of novel PIKFYVE gene mutations associated with fleck corneal dystrophy","volume":"21","author":"Gee","year":"2015","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2025.107053_bb0110","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","article-title":"Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons","volume":"29","author":"Gegg","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.nbd.2025.107053_bb0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0120","doi-asserted-by":"crossref","first-page":"ar26","DOI":"10.1091\/mbc.E21-06-0309","article-title":"PP2A-dependent TFEB activation is blocked by PIKfyve-induced mTORC1 activity","volume":"33","author":"Hasegawa","year":"2022","journal-title":"Mol. Biol. Cell"},{"issue":"20","key":"10.1016\/j.nbd.2025.107053_bb0125","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1016\/j.bmc.2006.06.046","article-title":"Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors","volume":"14","author":"Hayakawa","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.nbd.2025.107053_bb0130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","article-title":"Glucocerebrosidase activity modulates neuronal susceptibility to pathological alpha-Synuclein insult","volume":"105","author":"Henderson","year":"2020","journal-title":"Neuron"},{"issue":"34","key":"10.1016\/j.nbd.2025.107053_bb0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2320257121","article-title":"A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases","volume":"121","author":"Hou","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2009.03.063","article-title":"YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes","volume":"382","author":"Ikonomov","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.nbd.2025.107053_bb0145","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1074\/jbc.M111.222364","article-title":"The phosphoinositide kinase PIKfyve is vital in early embryonic development: preimplantation lethality of PIKfyve\u2212\/\u2212 embryos but normality of PIKfyve+\/\u2212 mice","volume":"286","author":"Ikonomov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2025.107053_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.taap.2018.08.001","article-title":"PIKfyve inhibitor cytotoxicity requires AKT suppression and excessive cytoplasmic vacuolation","volume":"356","author":"Ikonomov","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107053_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114771","article-title":"Small molecule PIKfyve inhibitors as cancer therapeutics: translational promises and limitations","volume":"383","author":"Ikonomov","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"41","key":"10.1016\/j.nbd.2025.107053_bb0160","doi-asserted-by":"crossref","first-page":"20760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120819","article-title":"Genetic and chemical activation of TFEB mediates clearance of aggregated alpha-synuclein","volume":"10","author":"Kilpatrick","year":"2015","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.nbd.2025.107053_bb0170","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson\u2019s disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107053_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104876","article-title":"Do Lewy bodies contain alpha-synuclein fibrils? And does it matter? A brief history and critical analysis of recent reports","volume":"141","author":"Lashuel","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2025.107053_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.2010.217836","article-title":"The bare essentials: Parkinson\u2019s disease","volume":"10","author":"Lees","year":"2010","journal-title":"Pract. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049750","article-title":"Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson\u2019s disease associated mutations A53T and E46K","volume":"8","author":"Lemkau","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.nbd.2025.107053_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcell.2019.00170","article-title":"Proteasome inhibition activates autophagy-lysosome pathway associated with TFEB Dephosphorylation and nuclear translocation","volume":"7","author":"Li","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"35","key":"10.1016\/j.nbd.2025.107053_bb0195","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.nbd.2025.107053_bb0200","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1093\/hmg\/ddw185","article-title":"Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease","volume":"25","author":"Magalhaes","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.nbd.2025.107053_bb0205","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41598-018-19479-8","article-title":"Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons","volume":"8","author":"Magalhaes","year":"2018","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.nbd.2025.107053_bb0210","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2571","article-title":"DQ-red BSA trafficking assay in cultured cells to assess cargo delivery to lysosomes","volume":"7","author":"Marwaha","year":"2017","journal-title":"Bio-Protoc."},{"issue":"1","key":"10.1016\/j.nbd.2025.107053_bb0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.nbd.2025.107053_bb0220","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"Alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 5","key":"10.1016\/j.nbd.2025.107053_bb0230","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","article-title":"Transcriptional activation of lysosomal exocytosis promotes cellular clearance","volume":"21","author":"Medina","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.nbd.2025.107053_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1152503","article-title":"Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson\u2019s disease","volume":"17","author":"Mubariz","year":"2023","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.nbd.2025.107053_bb0245","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107053_bb0250","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1038\/s41467-018-05862-6","article-title":"mTOR-dependent phosphorylation controls TFEB nuclear export","volume":"9","author":"Napolitano","year":"2018","journal-title":"Nat. Commun."},{"issue":"Pt 7","key":"10.1016\/j.nbd.2025.107053_bb0255","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0260","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ejhg.2016.186","article-title":"FIG 4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study","volume":"25","author":"Osmanovic","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2025.107053_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2019.03.1627","article-title":"Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies","volume":"495","author":"Paciotti","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"19","key":"10.1016\/j.nbd.2025.107053_bb0270","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.nbd.2025.107053_bb0275","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/15384101.2017.1337968","article-title":"AKT modulates the autophagy-lysosome pathway via TFEB","volume":"16","author":"Palmieri","year":"2017","journal-title":"Cell Cycle"},{"issue":"13","key":"10.1016\/j.nbd.2025.107053_bb0280","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107053_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2022.102086","article-title":"Roles of PIKfyve in multiple cellular pathways","volume":"76","author":"Rivero-Rios","year":"2022","journal-title":"Curr. Opin. Cell Biol."},{"issue":"12","key":"10.1016\/j.nbd.2025.107053_bb0290","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"issue":"5939","key":"10.1016\/j.nbd.2025.107053_bb0295","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.107053_bb0300","article-title":"PIKfyve inhibition blocks endolysosomal escape of \u03b1-synuclein fibrils and spread of \u03b1-synuclein aggregation","author":"See","year":"2021","journal-title":"bioRxiv"},{"issue":"6036","key":"10.1016\/j.nbd.2025.107053_bb0305","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.nbd.2025.107053_bb0310","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107053_bb0315","article-title":"Differentiation of the SH-SY5Y human neuroblastoma cell line","volume":"108","author":"Shipley","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"17","key":"10.1016\/j.nbd.2025.107053_bb0320","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6645","key":"10.1016\/j.nbd.2025.107053_bb0325","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.nbd.2025.107053_bb0330","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0335","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuron.2021.10.032","article-title":"Rescue of alpha-synuclein aggregation in Parkinson\u2019s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking","volume":"110","author":"Stojkovska","year":"2022","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.nbd.2025.107053_bb0340","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41422-020-0299-4","article-title":"Cryo-EM structure of full-length alpha-synuclein amyloid fibril with Parkinson\u2019s disease familial A53T mutation","volume":"30","author":"Sun","year":"2020","journal-title":"Cell Res."},{"issue":"23","key":"10.1016\/j.nbd.2025.107053_bb0345","doi-asserted-by":"crossref","first-page":"14794","DOI":"10.3390\/ijms232314794","article-title":"Development of p-tau differentiated cell model of Alzheimer’s disease to screen novel acetylcholinesterase inhibitors","volume":"23","author":"Uras","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107053_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/mds.30006","article-title":"Consensus guidance for genetic counseling in GBA1 variants: a focus on Parkinson\u2019s disease","author":"Vieira","year":"2024","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.nbd.2025.107053_bb0355","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tins.2019.10.002","article-title":"Lysosomal dysfunction at the centre of Parkinson\u2019s disease and frontotemporal dementia\/amyotrophic lateral sclerosis","volume":"42","author":"Wallings","year":"2019","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107053_bb0360","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.nbd.2025.107053_bb0365","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.stemcr.2017.01.011","article-title":"A human neural crest stem cell-derived dopaminergic neuronal model recapitulates biochemical abnormalities in GBA1 mutation carriers","volume":"8","author":"Yang","year":"2017","journal-title":"Stem Cell Reports"},{"issue":"14","key":"10.1016\/j.nbd.2025.107053_bb0370","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/hmg\/ddac038","article-title":"Ambroxol reverses tau and alpha-synuclein accumulation in a cholinergic N370S GBA1 mutation model","volume":"31","author":"Yang","year":"2022","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2025.107053_bb0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein","volume":"26","author":"Zhang","year":"2023","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:21:33Z","timestamp":1759299693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":74,"alternative-id":["S0969996125002694"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107053","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107053"}}